Richard D. Truesdell, Jr.
Lawyers
Filters
Davis Polk Advises Marsh & McLennan Companies, Inc. on Its €1.1 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. (MMC) in connection with its SEC-registered offering of €550 million aggregate principal amount of its 1.349% senior notes due 2026…
Hamilton Lane $66.7 Million Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $66.7 million SEC-registered follow-on offering of 1,449,303 shares of Class A common stock of Hamilton Lane…
Bandwidth Inc. Follow-On Offering
Davis Polk advised the representatives of the several underwriters in connection with Bandwidth Inc.’s follow-on offering of 2,875,000 shares of Class A common stock, which includes the…
Davis Polk Advises Tyson Foods on Its $2.8 Billion Senior Notes Offerings
Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $2.8 billion aggregate principal amount of senior notes in three series, consisting of $800 million…
HubSpot, Inc. $355 Million Common Stock Offering
Davis Polk advised the book-running manager and representative of the several underwriters in connection with the SEC-registered follow-on offering of 2,150,500 shares of common stock…
Steelcase Inc. $450 Million Senior Notes Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Steelcase Inc. of $450 million principal…
Stemline Therapeutics, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 10,222,222 shares of common stock of…
Alnylam Pharmaceuticals, Inc. $387.5 Million Common Stock Offering
Davis Polk advised the sole book-running manager of a $387.5 million SEC-registered offering of 5,000,000 shares of common stock of Alnylam Pharmaceuticals, Inc. Alnylam’s common stock is…
Davis Polk Advises Marsh & McLennan Companies on Its $5 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…
The Medicines Company $150 Million Convertible Notes Offering
Davis Polk advised the sole initial purchaser in connection with a Rule 144A offering by The Medicines Company of $150 million aggregate principal amount of 3.50% convertible senior…